Fidelity Disruptive Medicine ETF (FMED)

$26.18 +0.18 (0.69%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 1,130
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.

Latest News on FMED
Exploring Key Tailwinds for Fidelity's Disruptive ETFs

Jul 8, 2025, 1:36 PM EDT - 4 days ago

Exploring Key Tailwinds for Fidelity's Disruptive ETFs

FBOT FDCF FDFF FDIF FDTX

First Look At FMED: Poor Performance Merits A Strong Sell Rating

May 5, 2025, 12:12 PM EDT - 2 months ago

First Look At FMED: Poor Performance Merits A Strong Sell Rating

Why traditional active managers are joining the ETF space

Jul 24, 2023, 1:25 PM EDT - 2 years ago

Why traditional active managers are joining the ETF space

FBOT FDCF FDFF FDIF FDTX